KKR Credit Advisors (US) LLC sold $180M worth of shares in Amedisys, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Amedisys is a leading home health and hospice care company focused on bringing home the continuum of care. We deliver personalized home health and hospice care to thousands of patients and their families, in the comfort of their own homes. We focus on delivering the care that’s best for our patients, whether that is home-based recovery and rehabilitation after an operation or injury, care focused on empowering them to manage a chronic disease, palliative care for those with a terminal illness, or hospice care at the end of life.
KKR Credit Advisors employs a variety of strategies in managing the KKR Credit Funds and other investments, These strategies focus, primarily, on global leveraged credit strategies, such as leveraged loan and high yield bond strategies, alternative credit strategies (including mezzanine debt, special situations instruments, structured and illiquid credit, long/short credit, and direct senior loan origination and related instruments), and real assets. Certain KKR Credit Funds may also accommodate co-investments alongside KKR Funds including private equity funds and funds that invest in real assets. In pursuit of these strategies, KKR Credit may invest, from both a long or short investment perspective, in a broad range of securities and other financial instruments including: U.S. and non-U.S. debt securities including public and privately placed corporate and government bonds and other debt securities, equity securities, hybrid securities, stock market indices, exchange traded funds, convertibles, asset backed and other structured debt securities, emerging market debt, warrants, bank loans and participations in bank loans, repurchase agreements, foreign currency and interest rate forward contracts, swap agreements (including credit default swaps), options, commodities, futures contracts on intangibles and interests in partnerships investing in oil and gas and real estate interests and other derivative or synthetic investment instruments, and joint venture equity investments.